(Q73052683)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9026367%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

title

The synergistic effect of fluoxetine on the locomotor hyperactivity induced by MK-801, a non-competitive NMDA receptor antagonist (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9026367%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

J Maj

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9026367%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

K Wedzony

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9026367%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

publication date

1 January 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9026367%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neural Transmission

31 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9026367%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

103

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9026367%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9026367%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

131-146

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9026367%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf01292622

31 October 2019

exact match

0 references

cites work

Comparison of the behavioral and biochemical effects of the NMDA receptor antagonists, MK-801 and phencyclidine

1 reference

12 December 2020

Comparison of competitive and uncompetitive NMDA receptor antagonists with regard to monoaminergic neuronal activity and behavioural effects in rats

1 reference

12 December 2020

The receptor antagonist MK-801 induces increases in dopamine and serotonin metabolism in several brain regions of rats

1 reference

12 December 2020

The effect of intraventricular administration of the 5-HT3 receptor agonist 2-methylserotonin on the release of dopamine in the nucleus accumbens: an in vivo chronocoulometric study.

1 reference

12 December 2020

Gaps and peculiarities in 5-HT2 receptor studies

1 reference

12 December 2020

The effects of combined treatment with MK-801 and antidepressant drugs in the forced swimming test in rats

1 reference

12 December 2020

Neurochemical profile of the selective and silent 5-HT1A receptor antagonist WAY100135: an in vivo microdialysis study

1 reference

12 December 2020

Mixed agonist/antagonist properties of NAN-190 at 5-HT1A receptors: behavioural and in vivo brain microdialysis studies.

1 reference

12 December 2020

Facilitation of dopamine release in vivo by serotonin agonists: studies with microdialysis.

1 reference

12 December 2020

Fluoxetine and two other serotonin uptake inhibitors without affinity for neuronal receptors

1 reference

12 December 2020

Interfering with glutamatergic neurotransmission by means of NMDA antagonist administration discloses the locomotor stimulatory potential of other transmitter systems

1 reference

12 December 2020

MK-801 elevates the extracellular concentration of dopamine in the rat prefrontal cortex and increases the density of striatal dopamine D1 receptors

1 reference

12 December 2020

A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors

1 reference

12 December 2020

The third dopamine receptor (D3) as a novel target for antipsychotics

1 reference

12 December 2020

Functional correlates of serotonin 5-HT1 recognition sites

1 reference

12 December 2020

NAN-190: an arylpiperazine analog that antagonizes the stimulus effects of the 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT).

1 reference

12 December 2020

Immobility induced by forced swimming in rats: Effects of agents which modify central catecholamine and serotonin activity

1 reference

12 December 2020

The effect of antidepressant drugs on the locomotor hyperactivity induced by MK-801, a non-competitive NMDA receptor antagonist

1 reference

12 December 2020

MK-801 potentiates dopaminergic D1 but reduces D2 responses in the 6-hydroxydopamine model of Parkinson's disease

1 reference

12 December 2020

A new selective inhibitor for uptake of serotonin into synaptosomes of rat brain: 3-(p-trifluoromethylphenoxy). N-methyl-3-phenylpropylamine

1 reference

12 December 2020

The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor.

1 reference

12 December 2020

Differential effects of CGP 37849 and MK-801, competitive and noncompetitive NMDA antagonists, with respect to the modulation of sensorimotor gating and dopamine outflow in the prefrontal cortex of rats

1 reference

12 December 2020

NMDA receptors and in vivo dopamine release in the nucleus accumbens and caudatus.

1 reference

12 December 2020

[3H]MK-801 labels a site on the N-methyl-D-aspartate receptor channel complex in rat brain membranes

1 reference

12 December 2020

Is pindolol a mixed agonist-antagonist at central serotonin (5-HT) receptors?

1 reference

12 December 2020

The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist

1 reference

12 December 2020

MK-801 increases extracellular 5-hydroxytryptamine in rat hippocampus and striatum in vivo

1 reference

12 December 2020

Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs

1 reference

12 December 2020

Fluvoxamine, a new antidepressant drug, fails to show antiserotonin activity

1 reference

12 December 2020

Zacopride, a potent 5-HT3 antagonist

1 reference

12 December 2020

Functional antagonists at the NMDA receptor complex exhibit antidepressant actions

1 reference

12 December 2020

Interactions of phencyclidine receptor agonist MK-801 with dopaminergic system: regional studies in the rat.

1 reference

12 December 2020

Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin

1 reference

12 December 2020

Locomotor hyperactivity induced by MK-801 in rats

1 reference

12 December 2020

WAY100135: a novel, selective antagonist at presynaptic and postsynaptic 5-HT1A receptors

1 reference

12 December 2020

Release of endogenous dopamine by stimulation of 5-hydroxytryptamine3 receptors in rat striatum.

1 reference

12 December 2020

Tricyclic antidepressants block N-methyl-D-aspartate receptors: similarities to the action of zinc

1 reference

12 December 2020

The behavioural effects of MK-801 in rats: involvement of dopaminergic, serotonergic and noradrenergic systems

1 reference

12 December 2020

Antidepressant drugs increase the locomotor hyperactivity induced by MK-801 in rats

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01292622

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9026367%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference